End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
41.5 USD | -0.36% | -3.44% | -4.60% |
28/06 | National Atomic Company "Kazatomprom" JSC Announces Changes in the Management Board | CI |
12/06 | Kazatomprom Signs Subsoil Use Contract for Uranium Mining at Inkai 3 Deposit in Kazakhstan | MT |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
Strengths
- The earnings growth currently anticipated by analysts for the coming years is particularly strong.
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- The group's activity appears highly profitable thanks to its outperforming net margins.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
- The company has a low valuation given the cash flows generated by its activity.
- The company is one of the best yield companies with high dividend expectations.
- Over the last twelve months, the sales forecast has been frequently revised upwards.
- For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Analyst opinion has improved significantly over the past four months.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
- Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
Ratings chart - Surperformance
Sector: Uranium
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-4.60% | 1.04TCr | - | ||
+2.91% | 397.18Cr | - | C | |
+26.70% | 246.28Cr | - | B | |
+18.10% | 186.98Cr | B+ | ||
-12.74% | 100.85Cr | B- | ||
+22.94% | 85Cr | D | ||
+11.11% | 74Cr | - | - | |
+3.07% | 73Cr | - | - | |
+5.15% | 52Cr | - | - | |
-13.51% | 46Cr | - | C |
Financials
Valuation
Momentum
Consensus
Business Predictability
- Stock Market
- Equities
- KZAP Stock
- KZAPD Stock
- Ratings National Atomic Company Kazatomprom